Importance of screening for macroprolactin in all hyperprolactinaemic sera

Malaysian Journal of Pathology

Volumn 35, Issue 1, 2013, Pages 59-63

  Jamaluddin, Farhi Ain ^a   Sthaneshwar, Pavai ^a   Hussein, Zanariah ^a   Othman, Nor'ashikin ^b   Chan, Siew Peng ^c  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b PUTRAJAYA HOSPITAL   (Malaysia)

^c University Malaya   (Malaysia)

Author keywords

Gel filtration chromatography; Hyperprolactinaemia; Macroprolactin; PEG precipitation

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; MACROGOL; MACROPROLACTIN; PROLACTIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; GEL FILTRATION CHROMATOGRAPHY; HUMAN; HYPERPROLACTINEMIA; IMMUNOPRECIPITATION; INCIDENCE; INFERTILITY; MAJOR CLINICAL STUDY; MALE; MENSTRUAL IRREGULARITY; MICROADENOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY POLYCYSTIC DISEASE; PREVALENCE; PROLACTIN BLOOD LEVEL; PROLACTINOMA;

BLOOD CHEMICAL ANALYSIS; CHROMATOGRAPHY, GEL; FEMALE; HUMANS; HYPERPROLACTINEMIA; MALE; POLYETHYLENE GLYCOLS; PROLACTIN;

EID: 84879580904     PISSN: 01268635     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Luciano AA. Clinical presentation of hyperprolactinemia. J Reprod Med. 1999; 44(12 Suppl): 1085-90.
2. Suh HK, Frantz AG. Size heterogeneity of human prolactin in plasma and pituitary extracts. J Clin Endocrinol Metab. 1974; 39(5): 928-35.
3. Smith CR, Norman MR. Prolactin and growth hormone: molecular heterogeneity and measurement in serum. Ann Clin Biochem 1990; 27(Pt 6): 542-50.
4. Hattori N, Inagaki C. Anti-prolactin (PRL) autoantibodies cause asymptomatic hyperprolactinaemia: bioassay and clearance studies of PRLimmunoglobulin G complex. J Clin Endocrinol Metab. 1997; 82(9): 3107-110.
5. Smith TP, Suliman AM, Fahie-Wilson MN, McKenna TJ. Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays. J Clin Endocrinol Metab. 2002; 87(12): 5410-5.
6. Schneider W, Marcovitz S, Al-Shammari S, Yago S, Chevalier S. Reactivity of macroprolactin in common automated immunoassays. Clin Biochem. 2001; 34(6): 469-73.
7. Cavaco B, Prazeres S, Santos MA, Sobrinho LG, Leite V. Hyperprolactinemia due to big big prolactin is differently detected by commercially available immunoassays. J Endocrinol Invest. 1999; 22(3): 203-8.
8. Fahie-Wilson MN. Detection of macroprolactin causing hyperprolactinemia in commercial assays for prolactin. Clin Chem. 2000; 46(12): 2022-3.
9. McKenna TJ. Should macroprolactin be measured in all hyperprolactinaemic sera? Clin Endocrinol (Oxf). 2009; 71(4): 466-9.
10. Suliman AM, Smith TP, Gibney J, McKenna TJ. Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory defi nition of macroprolactinemia. Clin Chem. 2003; 49(9): 1504-9.
11. Fahie-Wilson MN, John R, Ellis AR. Macroprolactin; high molecular mass forms of circulating prolactin. Ann Clin Biochem. 2005; 42(Pt 3): 175-92.
12. Gibney J, Smith TP, McKenna TJ. Clinical relevance of macroprolactin. Clin Endocrinol (Oxf). 2005; 62(6): 633-43.
13. Fahie-Wilson M. In hyperprolactinemia, testing for macroprolactin is essential. Clin Chem. 2003; 49(9): 1434-6.
14. Schlechte JA. The macroprolactin problem. J Clin Endocrinol Metab. 2002;87:5408-9.
15. Fahie-Wilson MN. Polyethylene glycol precipitation as a screening method for macroprolactinemia. Clin Chem. 1999; 45(3): 436-7.
16. Fahie-Wilson MN, Soule SG. Macroprolactinaemia: contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol. Ann Clin Biochem. 1997; 34 (Pt 3): 252-8.
17. Olukoga AO, Kane JW. Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition. Clin Endocrinol (Oxf). 1999; 51(1): 119-26.
18. Jassam NF, Paterson A, Lippiatt C, Barth JH. Macroprolactin on the Advia Centaur: experience with 409 patients over a three-year period. Ann Clin Biochem. 2009; 46 (Pt 6): 501-4.
19. Beltran L, Fahie-Wilson MN, McKenna TJ, Kavanagh L, Smith TP. Serum total prolactin and monomeric prolactin reference intervals determined by precipitation with polyethylene glycol: evaluation and validation on common immunoassay platforms. Clin Chem. 2008; 54(10): 1673-81.